Methods to edit T cells for cancer immunotherapy

Francesca Lucibello, Silvia Menegatti, Laurie Menger

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Citations (Scopus)

Abstract

This chapter summarizes the recent findings regarding the development of gene-editing technologies applied to adoptive T cell immunotherapy for cancer. The emerging tools and strategies described below enable the generation of a tailored system, establishing T cells as an advanced biomaterial with redirected specificities that are both programmable and inducible and establish long-term antitumor potential. These reviewed techniques and strategies are implemented with an optimized protocol for the generation of CAR-T cells using lentiviral gene transfer.

Original languageEnglish
Title of host publicationTumor Immunology and Immunotherapy - Cellular Methods Part A
EditorsLorenzo Galluzzi, Nils-Petter Rudqvist
PublisherAcademic Press Inc.
Pages107-135
Number of pages29
ISBN (Print)9780128186732
DOIs
Publication statusPublished - 1 Jan 2020
Externally publishedYes

Publication series

NameMethods in Enzymology
Volume631
ISSN (Print)0076-6879
ISSN (Electronic)1557-7988

Keywords

  • Adoptive transfer
  • Cancer immunotherapy
  • T cells engineering

Cite this